<DOC>
	<DOCNO>NCT00279734</DOCNO>
	<brief_summary>Study assess ability healthy subject build anitbodies tetanus pneumococcal vaccine receive single intravenous dose Abatacept , drug develop treatment Rheumatoid Arthritis affect immune system .</brief_summary>
	<brief_title>Vaccination Study Abatacept ( BMS-188667 ) Normal Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>Healthy Subjects Body Weight 60 100 kg . Males Females must use adequate contraceptive method study 10 week dose study mediciation . Females prgnant breastfeed History autoimmune disorder , immunodeficiency , infection within past 3 month . Active TB require treatment within previous 3 year . Positive breast cancer screen , PPD test . Vaccination tetanus pneumococcal vaccine within 5 year . Vaccination live vaccine within 4 week . History drug alcohol abuse . Any significant allergy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>